Ketamine is increasingly being used as an off-label treatment for depression, but researchers have found it might not provide ...

Investigational seltorexant improved symptoms of major depressive disorder (MDD) and insomnia in people with an inadequate response to antidepressants, a phase III trial indicated. By week 6, the ...

Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have ...

Psilocybin could be the future of mental health care, with promising findings emerging from Australia's first research trial ...

Reasons to be Cheerful reports on the growing use of psilocybin in mental health treatment, showing promise for conditions ...

New research published in the Archives of General Psychiatry shows that children with ADHD are at an increased risk for depression and suicidal thoughts -- and very well may need treatment for both.

Jacintha was at her wits' end. Her daughter was struggling, and they had tried everything ‒ two types of antidepressants, years of talk therapy and weeks of an intensive outpatient program. There was ...

A new study shows longer-term use of generic ketamine for severe depression is safe and effective, but researchers say access ...

Until recently, clinical depression treatments have fallen into just two categories: psychotherapy and antidepressant medications. But this year, the U.S. Food and Drug Administration cleared the ...

The French Society for Biological Psychiatry and Neuropsychopharmacology has unveiled revised guidelines for the management of depressive disorders with partial and resistant responses to treatment.

The University of Iowa Health Care has introduced a new treatment for depression through its outpatient clinic — Stanford Accelerated Intelligent Neuromodulation Therapy, or SAINT therapy. The therapy ...

A comprehensive meta-analysis in depression and mortality, led by the Department of Psychiatry at the School of Clinical ...